The latest, most promising treatments
If you’re diagnosed with leukemia, you can’t wait six to 12 months for the FDA to approve a drug. You need it now. Our goal is to provide our patients with cutting-edge, groundbreaking therapies even before those treatments are widely available. For example, in 2017-2019, nine new therapies were approved by the FDA for the treatment of acute myeloid leukemia (AML). Patients enrolled in clinical trials at Roswell Park had access to seven of those drugs before they were FDA-approved.
We offer a wide range of clinical trials of new and promising treatments, including the latest immunotherapies and targeted therapies for patients with acute and chronic leukemia, as well as myeloid malignancies such as myelodysplastic syndrome and myeloproliferative neoplasms. We’re also among the centers authorized to provide the FDA-approved CAR T-cell therapy Kymriah® for young patients with acute lymphoblastic leukemia (up to age 25).
Nationally recognized experts who help set the standards
Experts on Roswell Park’s Leukemia team serve on the National Comprehensive Cancer Network (NCCN) panels that write the national guidelines for the diagnosis and treatment of leukemia and myeloid malignancies.
Every member of our clinical team has extensive subspecialty experience in diagnosing and treating leukemia and myeloid malignancies.
Hope for even very rare blood diseases
We have extensive knowledge of — and hands-on experience in — the management of uncommon and rare blood cancers. For example, the rare and aggressive blood cancer blastic plasmacytoid dendritic cell neoplasm (BPDCN) accounts for less than 1% of all hematologic cancers. Roswell Park was one of only eight centers nationwide to offer a clinical trial designed specifically to treat BPDCN using the drug tagraxofusp-eraz (Elzonris™). Four patients enrolled in the trial at Roswell Park. High response rates improved the lives of those patients and led the FDA to approve Elzonris as the new standard-of-care therapy for BPDCN in December of 2018.
Fast, early, accurate detection & diagnosis
Pathologists in Roswell Park’s Leukemia Service concentrate on diagnosing blood cancers — nothing but blood cancers —every single day, as part of a dedicated, highly skilled team specializing in the diagnosis of leukemia and myeloid malignancies.
Our Flow and Image Cytometry facility, recognized as one of the nation’s best, makes it possible to quickly identify your specific type of leukemia — information that will help your medical team create the best treatment plan for you. In addition, our dedicated genetic and molecular laboratories process our samples quickly and efficiently to determine the best treatment approach as soon as possible — usually within a few days.
One of the nation’s top centers for bone marrow transplant
If you need a bone marrow transplant (BMT), now or in the future, you’ll be in good hands in our Transplant & Cellular Therapy Center — ranked one of the nation’s best, based on patient survival.